FDA Clearance Tracker · K213345
Sentiero, AuDX, AuDX PRO, Sentiero Desktop, AuDX PRO Flex, Sentiero Advanced, NavPRO ONE
Last checked: Nov 19, 2026Latest source record: Jun 22, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Jun 22, 2022
Substantially Equivalent
Time to decision
257 days
Received Oct 8, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K213345
- Device name
- Sentiero, AuDX, AuDX PRO, Sentiero Desktop, AuDX PRO Flex, Sentiero Advanced, NavPRO ONE
- Applicant
- Path Medical GmbH
- Applicant location
- Germering, DE
- Received
- Oct 8, 2021
- Decided
- Jun 22, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Audiometer (EWO)
- Device class
- Class II
- Regulation
- 21 CFR 874.1050
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code EWO. The earliest in FDA's data is K760859, decided Oct 29, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K213345
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Path Medical GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- QScreen510(k)
K220139 · Decided Aug 3, 2022 · 197 days after receipt
Device type: Stimulator, Auditory, Evoked Response (GWJ) · Neurology & Neurosurgery
- ALGO 7i510(k)
K211147 · Decided Oct 14, 2021 · 178 days after receipt
Device type: Stimulator, Auditory, Evoked Response (GWJ) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.